Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
0.960
+0.044 (4.80%)
At close: Aug 8, 2022 4:00 PM
0.900
-0.060 (-6.250%)
After-hours:
Aug 8, 2022 7:45 PM EDT
Income Statement (Quarterly)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Quarter Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin
|
2.31 | 2.02 | 2.06 | 2.18 | 3.25 | 2.69 | 3.23 | 2.91 | 3.11 | 2.52 | 2.52 | 2.96 | 2.89 | 2.78 | 2.78 | 2.54 | 2.54 | 2.5 | 2.21 | 2.79 | 2.72 | 2.12 | 2.77 | 1.71 | 1.03 | 1.2 | 0.61 | 0.33 | 0.29 |
| Research & Development
|
5.1 | 4.79 | 6.99 | 9.11 | 8.23 | 7.19 | 6.62 | 7.86 | 10.16 | 8.92 | 9 | 10.64 | 9.42 | 8.39 | 8.37 | 9.72 | 12.1 | 9.69 | 10.73 | 12.39 | 13.5 | 9.13 | 7.71 | 7.12 | 5.4 | 4.91 | 2.51 | 2.01 | 1.92 |
| Operating Expenses
|
7.41 | 6.81 | 9.05 | 11.29 | 11.48 | 9.88 | 9.85 | 10.77 | 13.27 | 11.44 | 11.51 | 13.6 | 12.31 | 11.17 | 11.15 | 12.26 | 14.64 | 12.19 | 12.94 | 15.17 | 16.22 | 11.25 | 10.48 | 8.83 | 6.43 | 6.1 | 3.12 | 2.33 | 2.21 |
| Operating Income
|
-7.41 | -6.81 | -9.05 | -11.29 | -11.48 | -9.88 | -9.85 | -10.77 | -13.27 | -11.44 | -11.51 | -13.6 | -12.31 | -11.17 | -11.15 | -12.26 | -14.64 | -12.19 | -12.94 | -15.17 | -16.22 | -11.25 | -10.48 | -8.83 | -6.43 | -6.1 | -3.12 | -2.33 | -2.21 |
| Other Expense / Income
|
0.88 | 2.43 | 1.63 | 0.46 | 0.1 | -37.23 | -0.05 | -0.16 | -0.33 | -0.39 | -0.51 | -0.62 | -0.66 | -0.66 | -0.65 | -0.63 | -0.34 | -0.26 | -0.23 | -0.19 | -0.18 | -0.16 | -0.18 | -0.18 | -0.08 | -0.07 | 0.03 | 17.9 | -0.3 |
| Pretax Income
|
-8.3 | -9.24 | -10.67 | -11.75 | -11.58 | 27.35 | -9.8 | -10.61 | -12.94 | -11.05 | -11 | -12.98 | -11.64 | -10.51 | -10.5 | -11.63 | -14.3 | -11.93 | -12.72 | -14.98 | -16.04 | -11.09 | -10.3 | -8.65 | -6.35 | -6.04 | -3.15 | -20.23 | -1.91 |
| Net Income
|
-8.3 | -9.24 | -10.67 | -11.75 | -11.58 | 27.35 | -9.8 | -10.61 | -12.94 | -11.05 | -11 | -12.98 | -11.64 | -10.51 | -10.5 | -11.63 | -14.3 | -11.93 | -12.72 | -14.98 | -16.04 | -11.09 | -10.3 | -8.65 | -6.35 | -6.04 | -3.15 | -20.23 | -1.91 |
| Net Income Common
|
-8.3 | -9.24 | -10.67 | -11.75 | -11.58 | 27.35 | -9.8 | -10.61 | -12.94 | -11.05 | -11 | -12.98 | -11.64 | -10.51 | -10.5 | -11.63 | -14.3 | -11.93 | -12.72 | -14.98 | -16.04 | -11.09 | -10.3 | -8.65 | -6.35 | -6.04 | -3.15 | -20.23 | -1.91 |
| Shares Outstanding (Basic)
|
47 | 47 | 44 | 42 | 35 | 30 | 30 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 23 | 21 | 21 | 20 | 20 | 15 | 20 | 20 | 1 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted)
|
47 | 47 | 44 | 42 | 35 | 30 | 30 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 23 | 21 | 21 | 20 | 20 | 15 | 20 | 20 | 1 | 0 | 0 | 0 | 0 |
| Shares Change
|
34.88% | 57.14% | 48.97% | 43.56% | 17.35% | 0.86% | 0.38% | 0.41% | 0.41% | 0.29% | 1.04% | 1.14% | 29.72% | 41.81% | 41.88% | 41.87% | 10.96% | 34.06% | 1.57% | 2.34% | 1629.59% | 4027.48% | 5005.61% | 5662.98% | 295.98% | - | - | - | - |
| EPS (Basic)
|
-0.18 | -0.19 | -0.24 | -0.28 | -0.34 | 0.93 | -0.33 | -0.36 | -0.44 | -0.38 | -0.37 | -0.44 | -0.40 | -0.36 | -0.36 | -0.40 | -0.63 | -0.58 | -0.62 | -0.73 | -0.79 | -0.53 | -0.51 | -0.43 | -5.39 | -10.88 | -7.97 | -58.42 | -6.44 |
| EPS (Diluted)
|
-0.18 | -0.19 | -0.24 | -0.28 | -0.34 | 0.93 | -0.33 | -0.36 | -0.44 | -0.38 | -0.37 | -0.44 | -0.40 | -0.36 | -0.36 | -0.40 | -0.63 | -0.58 | -0.62 | -0.73 | -0.79 | -0.53 | -0.51 | -0.43 | -5.39 | -10.88 | -7.97 | -58.42 | -6.44 |
| Free Cash Flow Per Share
|
-0.14 | -0.15 | -0.19 | -0.30 | -0.26 | -0.28 | -0.27 | -0.32 | -0.32 | -0.29 | -0.36 | -0.31 | -0.31 | -0.29 | -0.38 | -0.38 | -0.49 | -0.53 | -0.53 | -0.58 | -0.63 | -0.65 | -0.34 | -0.35 | -5.31 | -12.85 | -8.49 | -6.55 | -8.91 |
| EBITDA
|
-8.21 | -9.14 | -10.57 | -11.63 | -11.44 | 27.49 | -9.65 | -10.45 | -12.75 | -10.86 | -10.82 | -12.79 | -11.46 | -10.33 | -10.27 | -11.41 | -14.08 | -11.71 | -12.51 | -14.77 | -15.83 | -10.9 | -10.14 | -8.5 | -6.24 | -5.98 | -3.1 | -20.2 | -1.91 |
| Depreciation & Amortization
|
0.09 | 0.09 | 0.11 | 0.12 | 0.14 | 0.14 | 0.15 | 0.16 | 0.18 | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 | 0.23 | 0.22 | 0.22 | 0.22 | 0.21 | 0.21 | 0.2 | 0.19 | 0.16 | 0.14 | 0.11 | 0.06 | 0.06 | 0.04 | 0 |
| EBIT
|
-8.3 | -9.24 | -10.67 | -11.75 | -11.58 | 27.35 | -9.8 | -10.61 | -12.94 | -11.05 | -11 | -12.98 | -11.64 | -10.51 | -10.5 | -11.63 | -14.3 | -11.93 | -12.72 | -14.98 | -16.04 | -11.09 | -10.3 | -8.65 | -6.35 | -6.04 | -3.15 | -20.23 | -1.91 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).